secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2024-03-26T23:59:59+00:00
Accession:  0001171843-24-001609
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience approves 2024 cash incentive plan for CEO and CFO
--------------------------------------------------------------------

- Compensation Committee approved 2024 annual cash incentive plan on March 21, 2024.
- CEO and CFO each assigned a target award as a percentage of 2024 base salary.
- Payout ranges from 0% to 150% of target based on corporate financial objectives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184324001609/0001171843-24-001609-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184324001609/f8k_032624.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-001609

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer